ATI RN
ATI Maternal Final Exam Questions
Extract:
A client receiving magnesium sulfate for pre-eclampsia
Question 1 of 5
A nurse is assessing a client who is receiving magnesium sulfate to treat pre-eclampsia. Which of the following findings should the nurse report to the provider?
Correct Answer: A
Rationale: Low urinary output (40 mL in 2 hr) may indicate magnesium sulfate toxicity or reduced renal perfusion, requiring immediate provider notification.
Extract:
A client having a difficult, prolonged labor with severe backache
Question 2 of 5
A nurse on the labor and delivery unit is caring for a client who is having a difficult, prolonged labor with severe backache. Which of the following contributing causes should the nurse identify?
Correct Answer: D
Rationale: A persistent occiput posterior position leads to difficult labor and backache as the fetal head's occipitofrontal diameter contacts the sacrum, causing prolonged pressure and pain.
Extract:
A client prescribed enoxaparin 30 mg subcutaneously with 40 mg/mL available
Question 3 of 5
A nurse is caring for a client who is to receive enoxaparin 30 mg subcutaneously. Available is enoxaparin 40 mg/mL. How many mL should the nurse administer?
Correct Answer: 0.8 mL
Rationale: 30 mg / 40 mg/mL = 0.75 mL, rounded to 0.8 mL per the nearest tenth as instructed.
Extract:
A client who is a primigravida at 42 weeks of gestation believing she is in labor
Question 4 of 5
A nurse midwife is examining a client who is a primigravida at 42 weeks of gestation and states that she believes she is in labor. Which of the following findings confirm to the nurse that the client is in labor?
Correct Answer: D
Rationale: Cervical dilation is a primary indicator of active labor, confirming the onset of true labor in a primigravida.
Extract:
A newborn whose mother is positive for the hepatitis B surface antigen
Question 5 of 5
A nurse is caring for a newborn whose mother is positive for the hepatitis B surface antigen. Which of the following should the infant receive?
Correct Answer: B
Rationale: Administering hepatitis B immune globulin and vaccine within 12 hours of birth provides passive and active immunity to prevent hepatitis B transmission from an HBsAg-positive mother.